PANCREAS ADENOCARCINOMA
Clinical trials for PANCREAS ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new PANCREAS ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for PANCREAS ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo treatment aims to boost pancreatic cancer surgery success
Disease control Recruiting nowThis study is for people with pancreatic cancer that can be removed by surgery. It tests whether giving chemotherapy and radiation before surgery can help surgeons remove all the cancer. About 30 adults will take part. The goal is to see if this approach leads to better outcomes.
Matched conditions: PANCREAS ADENOCARCINOMA
Phase: PHASE2 • Sponsor: Loma Linda University • Aim: Disease control
Last updated May 17, 2026 00:47 UTC
-
New chemo rotation may shrink pancreatic tumors enough for surgery
Disease control Recruiting nowThis study tests whether switching between two different chemotherapy combinations can help people with borderline resectable pancreatic cancer. The goal is to shrink the tumor enough for successful surgery and to improve survival without the cancer coming back. About 35 adults w…
Matched conditions: PANCREAS ADENOCARCINOMA
Phase: PHASE2 • Sponsor: Dartmouth-Hitchcock Medical Center • Aim: Disease control
Last updated May 17, 2026 00:44 UTC
-
New chemo sequence aims to shrink pancreatic tumors before surgery
Disease control Recruiting nowThis study tests whether giving two different chemotherapy combinations one after the other can shrink pancreatic tumors enough to allow successful surgery. About 64 adults with borderline resectable or locally advanced pancreatic cancer will receive gemcitabine plus nab-paclitax…
Matched conditions: PANCREAS ADENOCARCINOMA
Phase: PHASE2 • Sponsor: Wake Forest University Health Sciences • Aim: Disease control
Last updated May 17, 2026 00:30 UTC
-
New combo therapy aims to slash deadly leaks after pancreatic surgery
Disease control Recruiting nowThis study tests whether giving a short course of two medicines (hydrocortisone and octreotide) plus using a patch made from the patient's own tissue during surgery can lower the chance of serious complications after a Whipple procedure. The Whipple is a complex operation to remo…
Matched conditions: PANCREAS ADENOCARCINOMA
Phase: PHASE4 • Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) • Aim: Disease control
Last updated May 17, 2026 00:28 UTC
-
Targeted attack on hidden cancer: new trial for patients with undetectable tumor DNA
Disease control Recruiting nowThis study tests whether adding a special treatment sequence (called sequential cytoreductive intervention) to standard therapy can help people with advanced upper gastrointestinal cancers that have spread but show no detectable tumor DNA in the blood. About 54 adults with cancer…
Matched conditions: PANCREAS ADENOCARCINOMA
Phase: PHASE2 • Sponsor: Yale University • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
New antibody combo targets Hard-to-Treat cancers
Disease control Recruiting nowThis early-phase trial tests a new drug called ZM008, alone and with another drug (toripalimab), in people with advanced solid tumors that have stopped responding to standard treatments. The main goals are to find a safe dose and check for side effects. About 100 adults with canc…
Matched conditions: PANCREAS ADENOCARCINOMA
Phase: PHASE1 • Sponsor: Zumutor Biologics Inc. • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
Can your Tumor's DNA predict chemo success? new study aims to find out
Disease control Recruiting nowThis study looks at how the genetic makeup of pancreatic cancer affects response to FOLFIRINOX chemotherapy given before surgery. About 45 adults with non-metastatic pancreatic cancer will receive chemo, then have their tumors analyzed. The goal is to see if certain tumor types r…
Matched conditions: PANCREAS ADENOCARCINOMA
Phase: PHASE2 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Disease control
Last updated May 05, 2026 11:57 UTC
-
Genetic clues to muscle wasting in pancreatic cancer could lead to new treatments
Knowledge-focused Recruiting nowThis study looks at how a person's genes might affect their risk of developing cancer cachexia, a severe muscle wasting condition common in pancreatic cancer. Researchers will collect blood samples from 100 adults with pancreatic cancer to find genetic markers linked to weight lo…
Matched conditions: PANCREAS ADENOCARCINOMA
Sponsor: Wake Forest University Health Sciences • Aim: Knowledge-focused
Last updated May 17, 2026 00:32 UTC